Closed Trials

• A5207, Maintaining Options for Mothers Study (MOMS): A Phase II Randomized...

  Study Location: India

  Eligibility: Ages Eligible for Study:  13 Years and older   (Child, Adult, Senior) Sexes Eligible for Study:  Female...

  Enrollment: Closed

  Read More

• A5225: Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in...

  Study Location: India

  Eligibility: HIV-infected males and females ≥16 years of age presenting with their first episode of CM. Participants may not have received...

  Enrollment: Closed

  Read More

• A5253: Sensitivity and Specificity of Mycobacterium Tuberculosis Screening...

  Study Location: India

  Eligibility: Ages Eligible for Study:  13 Years and older   (Child, Adult, Senior) Sexes Eligible for Study:  All Accepts...

  Enrollment: Closed

  Read More

• A5273: Multicenter Study of Options for Second-Line Effective Combination...

  Study Location: India

  Eligibility: Human immunodeficiency virus (HIV)-1 infected adults (age ≥18 years) who have confirmed virologic failure on an...

  Enrollment: Closed

  Read More

• A5274: REMEMBER, Reducing Early Mortality and Early Morbidity by Empiric...

  Study Location: India

  Eligibility: Participating sites must have a regional TB incidence (i.e., the TB incidence within the site’s expected catchment area)...

  Enrollment: Closed

  Read More

• A5279, Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid...

  Study Location: India

  Eligibility: Ages Eligible for Study:   13 Years and older   (Child, Adult, Senior) Sexes Eligible for Study:   All Accepts...

  Enrollment: Closed

  Read More

• A5282: A Randomized, Phase II Trial to Compare an HPV Test-and-Treat...

  Study Location: India

  Eligibility: HIV-infected women 18 years of age or older. Eligible participants should have no history of major cervical procedures or...

  Enrollment: Closed

  Read More

• A5290, A Randomized, Phase 2b Study of a Double-Dose...

  Study Location: India

  Eligibility: Ages Eligible for Study:   18 Years and older   (Adult, Senior) Sexes Eligible for Study:   All Accepts Healthy...

  Enrollment: Closed

  Read More

• A5300/P2003: PHOENIx Feasibility Study

  Study Location: India

  Eligibility: Feasibility Study; N/A

  Enrollment: Closed

  Read More

• A5314: Effect of LDMTX on Inflammation in HIV-infected Individuals

  Study Location: Baltimore

  Eligibility: HIV-infected men and women ≥40 years old, who have been virologically suppressed on continuous antiretroviral therapy for at...

  Enrollment: Closed

  Read More

• A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment of Acute HCV in...

  Study Location: Baltimore

  Eligibility: Men and women > 18 years, HIV+ and currently on stable antiretroviral (ARV) medications or on for at least 8 weeks and be...

  Enrollment: Closed

  Read More

• A5342: Evaluating the Safety, Tolerability, and Effect of a Human...

  Study Location: Baltimore

  Eligibility: Ages Eligible for Study:   18 Years to 65 Years Genders Eligible for Study:   Both Accepts Healthy Volunteers:  ...

  Enrollment: Closed

  Read More

• HPTN 069: A Phase II Randomized, Double-Blind, Study of the Safety and...

  Study Location: Baltimore

  Eligibility: HIV-uninfected at-risk MSM and at-risk women > 18 years.

  Enrollment: Closed

  Read More

• P1060:  Phase II, parallel, randomized, clinical trials comparing the...

  Study Location: India

  Eligibility: HIV-infected infants and children ≥ 2 months to < 36 months of age who are eligible for ART as defined by the WHO...

  Enrollment: Closed

  Read More

• P1070, Dose-Finding and Pharmacogenetic Study of Efavirenz in HIV-Infected...

  Study Location: India

  Eligibility: Ages Eligible for Study:   3 Months to 35 Months   (Child) Sexes Eligible for Study:   All Accepts Healthy...

  Enrollment: Closed

  Read More

• P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for...

  Study Location: India

  Eligibility: Ages Eligible for Study:  up to 72 Months   (Child) Sexes Eligible for Study:  All Accepts Healthy Volunteers:...

  Enrollment: Closed

  Read More

• P1077BF: Breastfeeding Version of the PROMISE Study (Promoting Maternal and...

  Study Location: India

  Eligibility: Antepartum component - Pregnant HIV-infected women who intend to breastfeed and their infants. Late Presenters - Late...

  Enrollment: Closed

  Read More

• P1077FF: Formula Feeding Version of the PROMISE Study (Promoting Maternal...

  Study Location: India

  Eligibility: Antepartum Component – HIV-infected pregnant women who intend to formula feed (FF) (with and without HBV) with documented...

  Enrollment: Closed

  Read More

• P1078: A Phase IV Randomized Double-Blind Placebo-Controlled Trial to...

  Study Location: India

  Eligibility: Mother/infant pairs: HIV-infected pregnant women ≥ 14 weeks through ≤ 34 weeks (34 weeks, 6 days) gestation.

  Enrollment: Closed

  Read More

• P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics, Tolerability, and...

  Study Location:

  Eligibility: Ages Eligible for Study:   18 Years and older   (Adult, Senior) Sexes Eligible for Study:   Female Accepts...

  Enrollment: Closed

  Read More